Related Experiment Video
Updated: Jun 7, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
Pertussis-induced cough
1Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Roosevelt Drive, Headington, Oxford, OX3 7LF, United Kingdom.
Insights
Despite high vaccination rates, pertussis (whooping cough) remains common due to waning immunity. Diagnosis relies on symptoms like coughing and vomiting, with limited treatment options available for persistent cough.
Area of Science:
- Public Health
- Infectious Diseases
- Vaccinology
Background:
- Pertussis (whooping cough) is a vaccine-preventable disease with high UK vaccination coverage.
- Waning immunity from pertussis vaccines necessitates understanding persistent infections.
- Pertussis is frequently observed in individuals with persistent coughs.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of pertussis.
- To highlight challenges in pertussis diagnosis and management.
- To identify areas for future research in pertussis control.
Main Methods:
- Literature review of pertussis epidemiology and clinical presentation.
- Analysis of diagnostic indicators including paroxysmal coughing, vomiting, and whooping.
- Evaluation of diagnostic methods such as culture, PCR, and serology.
- Review of current treatment strategies and their efficacy.
Main Results:
- Pertussis diagnosis is challenging, with paroxysmal coughing being sensitive but not specific.
- Vomiting and whooping are stronger indicators of pertussis.
- Cough duration varies significantly between children and adults.
- Current treatments do not resolve pertussis-induced cough, only reducing infectious periods.
Conclusions:
- Pertussis remains a significant public health concern despite vaccination.
- Effective treatments for pertussis-induced cough are lacking.
- Further research is crucial for understanding pertussis epidemiology, improving treatments, and developing better diagnostic tools.
Abstract:
Pertussis (whooping cough) is one of the commonest vaccine preventable diseases in the UK, despite vaccination coverage being maintained for the last 15 years at over 90% among infants and the addition of a pre-school booster to the UK national immunisation programme in 2001. However, it is known that pertussis vaccine does not confer long-term immunity to clinical infection. Evidence of pertussis infection has been reported in 37% of children presenting in UK primary care and 20% of adolescents and adults presenting in Canadian health centres with persistent cough. In children and adults with persistent cough, paroxysmal coughing is the most sensitive indicator of pertussis, but has poor specificity and limited diagnostic value. Vomiting and whooping, particularly in combination, are stronger predictors of pertussis. Cough duration is longer in children than in adults with pertussis (median cough duration 112 days versus 42 days); individuals may take even longer to recover fully and regain previous levels of exercise tolerance. A diagnosis of pertussis may be confirmed by culture, Polymerase Chain Reaction (PCR) or serology. Single estimates of anti-pertussis toxin (PT) antibody titres in blood or oral fluid samples are highly specific. There are currently no proven efficacious treatments for pertussis-induced cough. Treatment with macrolide antibiotics reduces the duration of an individual's infectious period, but does not alter the duration of cough. Further research is needed to re-examine the epidemiology of pertussis in countries with different vaccination schedules, find efficacious treatments and develop methods of measuring cough frequency and severity in patients with pertussis-induced cough.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pulmonary Cycle: Exhalation
Pneumonia II: Pathophysiology
Diphtheria
Tuberculosis
Atypical Pneumonia

